Clinical Trials Browser

Phase 1 × Advanced Tumors × toripalimab × Clear all

NCT05061628 2021-09-29

The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor

Phase 1 Unknown

Advanced Tumors